FDA-Cleared Nanotechnology developed by Nanovis is planned for use to enhance Medtronic PEEK interbody fusion devices used in ...

Here are five headlines to know about Medtronic, as reported by Becker's since Jan. 7: 1. Medtronic acquired rights and intellectual property related to Nanovis' Sites Medical's OsteoSync titanium ...

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

Nanovis announced today that it sold certain nano surface technology assets and certain IP rights to Medtronic.

Medtronic acquired rights and intellectual property related to Nanovis' Sites Medical's OsteoSync titanium pads, according to a Feb. 12 news release.

Nanovis, a leading developer and provider of nano surface technology that improves the biologic fixation of orthopedic, spine ...

The Inceptiv spinal cord stimulation system. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord ...

Medtronic has hired a new chief financial officer away from French carmaker Renault. The Dublin-based medical-device maker said Tuesday that Thierry Pieton will take on the CFO role starting March ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

Among those presenting, Medtronic CEO Geoff Martha outlined multiple growth drivers in the pipeline, zeroing in on pulsed field ablation (PFA), renal denervation, neuromodulation and automated insulin ...